Türkan GÜNAY, Ahmet SOYSAL, Hatice ŞİMŞEK, Sinem DOĞANAY

Prevalence of Metabolic Syndrome and Affecting Factors among Individuals Aged 30 and over in Balçova District of İzmir

Background: The studies have shown that metabolicsyndrome (MetS) leads to an increase twice as much incardiovascular diseases (CVD) and four times as much indiabetes mellitus (DM) prevalence since the second halfof the 20th century.Aims: This study aims to determine and discuss the prevalenceof the MetS and co- factors among individuals atthe age of 30 and over in Balcova district of İzmir provinceaccording to the American National Cholesterol EducationProgram - Adult Treatment Panel III (NCEP ATPIII) and InternationalDiabetes Federation (IDF) criteria.Study Design: Cross-sectional study.Methods: Data obtained from the Balcova Heart Projectin İzmir were used in the study. The dependent variableof the study is MetS existence. The independent variableswere socio-demographic characteristics (age, gender,education level, and marital status), self-perceived economicstatus, physical activity, smoking status, healthynutrition and body mass index (BMI).Results: The prevalence of MetS was 36.9% according tothe diagnostic criteria of IDF, while it was 27.4% accordingto ATP III criteria. According to the both criteria, increasingage, low education, poor economic status perception,physical inactivity, and obesity increase the risk of MetS.Apart from the IDF criteria, being female and a currentsmoker increase the risk of the MetS in the NCEP-ATP III.Conclusion: Compared to educational studies of MetS asof today, which are community and health-oriented studies,it is challenging that the prevalence of MetS was foundto be high for both criteria in our study. Therefore, in particular,primary health care doctors must be prompted toprotect the public against DM and CVD in particular.

PDF

___

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607. [CrossRef]
2. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 1993;44:121- 31. [CrossRef]
3. Gedik O. Metabolik sendromun tanımı ve tanı kriterleri. Klinik Aktüel Tıp, 2005; Metabolik sendrom özel sayısı, 5:1-5.
4. Alberti KG, Zimmet PZ. Provisional report of a WHO consultation Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis. Diabet Med 1998;15:539-53. [CrossRef]
5. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European group for the study of insulin resistance (EGIR). Diabet Med 1999;16:442-3. [CrossRef]
6. National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3142-421.
7. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Internatioanl Diabetes Federation 2006 Available from: http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf
8. Soysal A, Demiral Y, Soysal D, Uçku R, Köseoğlu M, Aksakoğlu G. The prevalence of metabolic syndrome among young adults in Izmir, Turkey. Anadolu Kardiyol Derg 2005;5:196-201.
9. Santos AC, Ebrahim S, Barros H. Gender, socio-economic status and metabolic syndrome in middle-aged and old adults. BMC Public Health 2008;8:62. [CrossRef]
10. Hoang CK, Ghandeari H, Lopez VA, Barboza MG, Wong ND. Global coronary heart disease risk assessment of individuals with the metabolic syndrome in the U.S. Diabetes Care 2008;31:1405-9. [CrossRef]
11. Tanyolaç S, Çıkım AS, Azezli AD, Orhan Y. Correlation between educational status and cardiovascular risk factors in an overweight and obese Turkish female population. Anadolu Kardiol Derg 2008;8:336-41.
12. Onat A, Sarısoy V. Halkımızda koroner hastalığın baş suçlusu metabolik sendrom: sıklığı, unsurları, koroner risk ile ilişkisi ve yüksek risk kriterleri. Türk Kardiyoloji Dern Arş 2002;30:8-15.
13. Ergör G, Soysal A, Sözmen K, Ünal B, Uçku R, Kılıç B, et al. Balçova Heart Study: rationale and methodology of Turkish cohort. Int J Public Health 2012;535-42. [CrossRef]
14. Athyros VG, Ganotakis ES, Bathianaki M, Mönedas I, Goudevenos IA, Papageorgiou AA, et al. Awareness, treatment and control of the metabolic syndrome and its components: A Multicentre Greek Study. Hellenic J Cardiol 2005;46:380-6.
15. Santos AC, Barros H. Impact of metabolic syndrome definitions on prevalence estimates: A study in a Portuguese Community. Diab Vasc Dis Res 2007;4:320-7. [CrossRef]
16. Moebus S, Hanisch JU, Aidelsburger P, Bramlage P, Wasem J, Jöcke KH. Impact of the metabolic syndrome in primary healthcare: The German metabolic and cardiovascular risk project (GEMCAS). Cardiovasc Diabetol 2007;6:22. [CrossRef]
17. Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Agespecific prevalence of the metabolic syndrome defined by the national cholesterol education program: The Norwegian HUNT 2 Study. BMC Public Health 2007;7:220. [CrossRef]
18. Matei C, Pop I, Jurgut R, Suceveanu M, Predescu D, Nechita E, et al. ROmanian multicentric study of the prevalence of MEtabolic Syndrome-ROMES. Hellenic J Cardiol 2008;49:303-9.
19. Kanjilal S, Shanker J, Rao V, Khadrinarasimhaih N, Mukherjee M, Iyengar S, et al. Prevalence and component Analysis of Metabolic Syndrome: An Indian atherosclerosis research study perspective. Vasc Health Risk Manag 2008;4:189-97. [CrossRef]
20. Xiang Y, Huang G, Zhou W, Che Z, Zhou P, Zhou Z. Prevalence of metabolic syndrome (MetS) in Chinese subjects gradually increased with impaired glucose homeostasis: a multicenter, clinical based, cross-sectional study. BMC Public Health 2012. [CrossRef]
21. Morales D, Punzalan EF, Pacheco E, Sy RG. Metabolic Syndrome in the Philippine General Populatin: Prevalence and risk for atherosclerotic cardiovascular disease and diabetes mellitus. Diabetes Vasc Dis Res 2008;5:36-43. [CrossRef]
22. Moy FM, Bulgiba A. The Modified NCEP ATP III Criteria maybe better than the IDF criteria in diagnostic metabolic syndrome among Malays in Kuala Lumpur. BMC Public Health 2010;10:678. [CrossRef]
23. Mujika V, Leiva A, Icaza G, Diaz N, Arredonto M, Carrasco R, et al. Evaluation of metabolic syndrome in adults of Talca City, Chile. Nutr J 2008;7-14. [CrossRef]
24. Rojas R, Salinas C, Corana A, Leavy T, Nut L, Rauda J, et al. Metabolic Syndrome in Mexican Adults. Results from the National Health and Nutrition Survey 2006. Salud Publica Mex 2010; 52(Suppl 1):511-8. [CrossRef]
25. Kelliny C, William J, Riesen W, Pascaud F, Bovet P. Metabolic Syndrome According to different definitions in a rapidly developing country of the African Region. Cardiovasc Diabetol 2008;7:27. [CrossRef]
26. Ramli AS, Daher A, Ashikin MNK, Nasir N, Ng KK, Miskan M, et al. JIS Defination identified more Malaysian adults with metabolic syndrome compared to the NCEP-ATP III and IDF Criteria. Biomed Res Int 2013;1-10. [CrossRef]
27. Ivezic-Lalic D, Markoviç BB, Kranjceviç K, Kern J, Vrdoljak D, Vucak J. Med Sci Monit 2013;19:571-8. [CrossRef]
28. Cai H, Huang J, Xu G, Yang Z, Liu M, Mi Y, et al. Prevalence and determinants of metabolic syndrome among women in Chinese Rural Areas. PloS One 2012;7:e36936. [CrossRef]
29. Shafique K, Mirza SS, Mughal MK, Arain ZI, Khan NA, Tareen MF, et al. Water-Pipe smoking and metabolic syndrome: A Population-Based Study. PLoS One 2012;7:e39734. [CrossRef]